FIELD: medicine.
SUBSTANCE: presented is using 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine hydrobromide as an agent changing the total spectrum power of the heart rate variability and possessing anti-bradycardia properties. The effect of the invention can be used if it is necessary to increase the heart rate if it has dipped down, which can constitute an immediate risk of loss of the individual's life caused by a high risk of cardiac arrest emergency.
EFFECT: reducing the power of a high-frequency component of the cardiac rhythm spectrum by several times, reducing a RR interval variability factor by reducing the regulatory effect of the parasympathetic nervous system on the cardiac rhythm.
8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING HEART RATE VARIABILITY IN SMALL CHILDREN | 2009 |
|
RU2414167C1 |
| METHOD FOR SELECTION OF PULSATURIZATION THERAPY THERAPY OF STABLE STENOCARDIUM IN PERSONS OF ELDERLY AND SENIOR AGE | 2015 |
|
RU2621304C2 |
| METHOD FOR DETECTING DYSFUNCTION IN ENDOTHELIUM OF CORONARY ARTERIES | 2001 |
|
RU2199266C1 |
| METHOD OF DETERMINING PSYCHOVEGETATIVE ORGANISM DISORDERS | 2012 |
|
RU2489085C1 |
| METHOD FOR PREDICTING SEVERITY DEGREE OF AUTONOMIC DYSTONIA SYNDROME | 2003 |
|
RU2258458C2 |
| USE OF SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION | 2018 |
|
RU2704920C1 |
| METHOD FOR PREDICTING RISK OF DYSAPTATION OF CARDIAC ACTIVITY IN CHILDREN WITH EPILEPSY | 2017 |
|
RU2675703C1 |
| METHOD FOR STUDYING HEART RATE VARIABILITY WITH UNDERLYING ANTIARRHYTHMIC THERAPY | 2018 |
|
RU2707263C2 |
| METHOD FOR EARLY DIAGNOSIS OF AUTONOMIC CARDIAC NEUROPATHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC DISORDERS | 2015 |
|
RU2585741C1 |
| METHOD OF REGULATORY RESOURCE ADAPTATION ABILITY ASSESSMENT FOR TEENAGERS | 2007 |
|
RU2344749C1 |
